Our proprietary efficacy models resulting from our Research and Development activity are a strategic decision-making support before clinical trials.
Our translational models are well suited for Proof of Concept (POC) studies in several therapeutic areas critical for Human health.
The study parameters are adapted to each project and goal, from the sampling method to the types of in vivo and ex vivo investigations.
To address particular issues relevant to patients, we can refine the characterisation of our models based on the sponsor’s need, or combine several models.
More information on: